Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Picci

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Orphanet Journal of Rare Diseases|January 25, 2007
Osteosarcoma (osteogenic sarcoma)Piero Picci
Current Opinion in Oncology|June 6, 2008
Targeting insulin-like growth factor 1 receptor in sarcomasKatia Scotlandi, Piero Picci
Current Opinion in Oncology|June 4, 2005
Adjuvant chemotherapy for soft tissue sarcomaPaolo G Casali, Piero Picci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Prognostic value of P-glycoprotein in high-grade osteosarcomaMassimo Serra, Piero Picci, Stefano Ferrari, et al.
Technology in Cancer Research & Treatment|April 3, 2019
Malignancy in Giant Cell Tumor of Bone: A Review of the LiteratureEmanuela Palmerini, Piero Picci, Peter Reichardt, et al.
Pathology, Research and Practice|July 29, 2016
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomasIsidro Machado, Samuel Navarro, Piero Picci, et al.
Sarcoma|June 4, 2008
Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centresSamuel Ford, Adnan Saithna, Robert J Grimer, et al.
Expert Opinion on Emerging Drugs|August 10, 2010
Emerging drugs for high-grade osteosarcomaClaudia Maria Hattinger, Michela Pasello, Stefano Ferrari, et al.
Frontiers in Endocrinology|June 2, 2015
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell LinesCecilia Garofalo, Mariantonietta Capristo, Caterina Mancarella, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2005
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, ItalyGaetano Bacci, Alessandra Longhi, Franca Fagioli, et al.
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Orphanet Journal of Rare Diseases|January 25, 2007
Osteosarcoma (osteogenic sarcoma)Piero Picci
Current Opinion in Oncology|June 6, 2008
Targeting insulin-like growth factor 1 receptor in sarcomasKatia Scotlandi, Piero Picci
Current Opinion in Oncology|June 4, 2005
Adjuvant chemotherapy for soft tissue sarcomaPaolo G Casali, Piero Picci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Prognostic value of P-glycoprotein in high-grade osteosarcomaMassimo Serra, Piero Picci, Stefano Ferrari, et al.
Technology in Cancer Research & Treatment|April 3, 2019
Malignancy in Giant Cell Tumor of Bone: A Review of the LiteratureEmanuela Palmerini, Piero Picci, Peter Reichardt, et al.
Pathology, Research and Practice|July 29, 2016
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomasIsidro Machado, Samuel Navarro, Piero Picci, et al.
Sarcoma|June 4, 2008
Comparison of the outcome of conventional osteosarcoma at two specialist international orthopaedic oncology centresSamuel Ford, Adnan Saithna, Robert J Grimer, et al.
Expert Opinion on Emerging Drugs|August 10, 2010
Emerging drugs for high-grade osteosarcomaClaudia Maria Hattinger, Michela Pasello, Stefano Ferrari, et al.
Frontiers in Endocrinology|June 2, 2015
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell LinesCecilia Garofalo, Mariantonietta Capristo, Caterina Mancarella, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2005
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, ItalyGaetano Bacci, Alessandra Longhi, Franca Fagioli, et al.
Pageof 28